APA (7th ed.) Citation

Bouazza, N., Urien, S., Foissac, F., Choupeaux, L., Lui, G., Froelicher Bournaud, L., . . . Sermet-Gaudelus, I. (2024). Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis. Clinical Pharmacokinetics, 63(3), 333-342. https://doi.org/10.1007/s40262-023-01342-3

Chicago Style (17th ed.) Citation

Bouazza, Naïm, et al. "Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis." Clinical Pharmacokinetics 63, no. 3 (2024): 333-342. https://doi.org/10.1007/s40262-023-01342-3.

MLA (9th ed.) Citation

Bouazza, Naïm, et al. "Lumacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients with Cystic Fibrosis." Clinical Pharmacokinetics, vol. 63, no. 3, 2024, pp. 333-342, https://doi.org/10.1007/s40262-023-01342-3.